Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Details) - Schedule of options granted outstanding and exercise prices

v3.22.1
Share Capital (Details) - Schedule of options granted outstanding and exercise prices - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Schedule of options granted outstanding and exercise prices [Abstract]    
Number of options, Outstanding at beginning 1,814,381 1,714,039
Weighted average exercise price, Outstanding at beginning $ 0.58 $ 0.63
Number of options, Granted 14,678,734 207,500
Weighted average exercise price, Granted $ 0.07 $ 0.27
Number of options, Options forfeited (173,329) (107,158)
Weighted average exercise price, Options forfeited $ 0.74 $ 0.88
Number of options, Outstanding at ending 16,319,786 1,814,381
Weighted average exercise price, Outstanding at ending $ 0.12 $ 0.58
Weighted average remaining contractual life (years), Outstanding at ending 5 years 9 months 14 days 6 years 7 months 28 days
Aggregate intrinsic-value, Outstanding at ending $ 2,581,719 $ 24,538
Number of options, Exercisable 5,913,492 1,209,464
Weighted average exercise price, Exercisable $ 0.14 $ 0.68
Weighted average remaining contractual life (years), Exercisable 5 years 4 months 24 days 5 years 8 months 19 days
Aggregate intrinsic-value, Exercisable $ 844,712 $ 24,538